Publication | Open Access
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
644
Citations
22
References
1989
Year
Microbial PathogensHumoral ResponseImmunologyPathologyImmunologic MechanismLd100 DoseInflammationLethal BacteremiaMab PretreatmentNecrosis FactorInflammatory MarkerImmune MediatorLive Escherichia ColiAutoimmunityHumoral ImmunityImmune FunctionInterleukin 6Clinical MicrobiologyCytokinePathogenesisMedicine
Cytokines secreted in response to invading micro-organisms are important mediators of detrimental hemodynamic and metabolic changes in the host. To test whether cachectin/TNF plays a role in triggering release of other cytokines in the setting of infection, anesthetized baboons were passively immunized against systemic cachectin/TNF before infusion of a LD100 dose of live Escherichia coli. Bacteremia led to significant increases in circulating levels of cachectin/TNF, IL-1 beta, and IL-6. Although bacterial endotoxin/lipopolysaccharide is a potent stimulus for the synthesis and release of IL-1 and IL-6 in vitro, specific neutralization of cachectin/TNF in vivo with mAb pretreatment significantly attenuated both the IL-1 beta and the IL-6 responses despite fulminant overwhelming bacteremia. These data suggest that cachectin/TNF is essential for the initiation or amplification of IL-1 and IL-6 release during lethal gram-negative septic shock syndrome.
| Year | Citations | |
|---|---|---|
Page 1
Page 1